The cyclic dinucleotide 2′3′-cGAMP, produced by the DNA sensor cGAS, was shown to have a noncanonical function beyond type I interferon induction: it both primes and activates an inflammasome dependent on AIM2, NLRP3, ASC, and caspase-1. The molecular mechanism of this activation is unresolved. Three linked questions remain open: (1) the precise role of STING in the activation step — STING is dispensable for transcriptional priming when that priming is supplied by an exogenous first signal such as lipopolysaccharide (LPS), yet required for optimal IL-1β secretion after cGAMP, and later studies propose non-equivalent mechanisms (STING-induced lysosomal cell death upstream of NLRP3 in human myeloid cells; direct STING–NLRP3 binding with ER recruitment and deubiquitination in DNA-virus infection) that remain unreconciled; (2) whether 2′3′-cGAMP physically interacts with specific inflammasome components directly or is recruited indirectly, since it colocalizes with AIM2, NLRP3, ASC, and caspase-1 in single inflammasome foci but no direct binding has been demonstrated; and (3) how AIM2 and NLRP3 cooperate within one inflammasome focus — separate sensor oligomers aggregating versus hetero-oligomeric sensor complexes, and how pyrin-domain geometry permits ASC polymerization in mixed-sensor complexes.

Background

Innate immune cells detect cytosolic microbial or host DNA with two major, classically separate systems. The enzyme cGAS (cyclic GMP–AMP synthase) binds cytosolic double-stranded DNA and synthesizes the small cyclic dinucleotide second messenger 2′3′-cGAMP; 2′3′-cGAMP then binds the adaptor protein STING (stimulator of interferon genes) on the endoplasmic reticulum to induce type I interferon through the kinases and transcription factors TBK1 (TANK-binding kinase 1) and IRF3 (interferon regulatory factor 3). In parallel, inflammasomes are multi-protein complexes that activate inflammatory cell death: a pattern-recognition sensor (such as AIM2, a protein whose HIN domain — a DNA-binding domain — directly recognizes cytosolic DNA, or NLRP3, a sensor of diverse homeostatic disruptions) nucleates polymerization of the adaptor ASC (apoptosis-associated speck-like protein containing a CARD), which recruits and activates the protease caspase-1; caspase-1 matures the cytokines IL-1β and IL-18 and, via gasdermin D membrane pores, typically drives pyroptosis, a lytic inflammatory cell death. Inflammasome activation conventionally needs two signals: a priming signal (e.g., Toll-like-receptor-driven NF-κB, a family of inducible transcription factors, or type I interferon signaling) that up-regulates sensor and pro-IL-1β expression, and an activation signal that assembles the complex.

Swanson et al. (J Exp Med 2017, DOI 10.1084/jem.20171749) reported that 2′3′-cGAMP itself supplies both signals in mouse macrophages and human cells: cGAMP alone primes inflammasome-component expression through type I interferon, and, given priming, cGAMP activates IL-1β secretion through a process dependent on AIM2, NLRP3, ASC, and canonical caspase-1. Confocal microscopy with fluorescein-labeled 2′3′-cGAMP showed the nucleotide colocalizing with DNA, AIM2, NLRP3, ASC, and caspase-1 in single cytosolic foci. In mice, the cGAS–cGAMP axis amplified both interferon and inflammasome outputs to control murine cytomegalovirus (MCMV), and cGAMP-driven IL-1β secretion notably occurred without substantial pyroptosis. Structural precedent (Lu et al., Cell 2014, DOI 10.1016/j.cell.2014.02.008) holds that activated AIM2 or NLRP3 sensors form ring-like oligomers whose pyrin domains (PYD, the N-terminal protein–protein interaction domain through which sensors nucleate ASC polymerization) seed ASC filaments, which is why co-residence of two sensors of different sizes in one focus poses a geometric puzzle.

The paper explicitly left the mechanism open, and subsequent work has deepened rather than settled it. STING proved dispensable for the transcriptional priming step when that priming was supplied by LPS yet partially required for IL-1β secretion after cGAMP ("future work is needed to fully elucidate its role"). Concurrently, Gaidt et al. (Cell 2017, DOI 10.1016/j.cell.2017.09.039) found that in human monocytes AIM2 is dispensable for DNA-induced inflammasome activation: activated STING traffics to lysosomes, permeabilizes them, and the resulting lysosomal cell death and potassium efflux activate NLRP3 — a species- and cell-type-discordant account. Wang et al. (PLoS Pathog 2020, DOI 10.1371/journal.ppat.1008335) proposed instead that STING directly binds NLRP3, recruits it to the endoplasmic reticulum, and promotes NLRP3 deubiquitination (removal of the polyubiquitin chains that keep NLRP3 inactive) during herpes simplex virus 1 (HSV-1) infection, without identifying the responsible deubiquitinase or testing the cGAMP-transfection setting. Photoaffinity-probe interactome studies have mapped cellular 2′3′-cGAMP-binding proteins (e.g., Rab18, a small Rab-family GTPase) in non-myeloid cells but have not reported direct binding of 2′3′-cGAMP to AIM2, NLRP3, ASC, or caspase-1, and reviews through 2026 continue to describe cGAS–STING–inflammasome crosstalk as incompletely resolved mechanistically. A further methodological caveat is that lipid transfection reagents alone can activate interferon signaling in macrophages, complicating attribution of effects in cGAMP-transfection experiments.

Problem Statement

Determine the molecular mechanism by which the mammalian second messenger 2′3′-cGAMP activates the AIM2/NLRP3 inflammasome, resolving three linked, explicitly flagged sub-questions of Swanson et al. (2017): (1) the precise molecular role of STING in the activation step — why STING is dispensable for the transcriptional priming of inflammasome components when that priming is supplied by LPS yet required for optimal IL-1β secretion after cGAMP, and how the partially STING-dependent activation observed in mouse macrophages relates to the proposed STING-driven lysosomal-cell-death pathway in human myeloid cells and the direct STING–NLRP3 binding/ER-recruitment/deubiquitination pathway described in DNA-virus infection, i.e., which molecular events are necessary and sufficient for cGAMP-induced inflammasome activation in each cell type; (2) the biochemical nature of the interaction between 2′3′-cGAMP and the inflammasome machinery — whether 2′3′-cGAMP binds AIM2, NLRP3, ASC, caspase-1, or another component directly, or is recruited into inflammasome foci indirectly through other factors; and (3) the structural organization of the mixed AIM2–NLRP3 inflammasome — whether separate AIM2- and NLRP3-centered oligomeric units aggregate on polymerized ASC, or hetero-oligomeric sensor complexes form, and how pyrin-domain geometry permits ASC polymerization in a focus containing both sensors. The overarching objective is a mechanistic account, valid across the relevant cell types and in vivo settings, of how one cyclic-dinucleotide second messenger coordinates interferon signaling with inflammasome activation, including the cell-type-specific balance between cGAMP-driven cytokine secretion and cell death. Resolving the task requires a single literature-grounded mechanistic account rather than new experimental evidence, answering all three sub-questions jointly, each with a proposed candidate mechanism together with the supporting and conflicting evidence. The three sub-questions are jointly mandatory, and the closing objective is their integration rather than a separate deliverable: the cell-type-specific balance between cGAMP-driven cytokine secretion and cell death belongs to the cell-type analysis required by sub-question (1).

References

  1. Swanson KV, Junkins RD, Kurkjian CJ, Holley-Guthrie E, Pendse AA, El Morabiti R, Petrucelli A, Barber GN, Benedict CA, Ting JPY. A noncanonical function of cGAMP in inflammasome priming and activation. Journal of Experimental Medicine 214(12):3611–3626, 2017. DOI: 10.1084/jem.20171749. https://doi.org/10.1084/jem.20171749
  2. Kuriakose T, Kanneganti TD. cGAMP: A tale of two signals. Journal of Experimental Medicine 214(12):3471–3473, 2017. DOI: 10.1084/jem.20171925. https://doi.org/10.1084/jem.20171925
  3. Gaidt MM, Ebert TS, Chauhan D, Ramshorn K, Pinci F, Zuber S, O'Duill F, Schmid-Burgk JL, Hoss F, Buhmann R, Wittmann G, Latz E, Subklewe M, Hornung V. The DNA inflammasome in human myeloid cells is initiated by a STING-cell death program upstream of NLRP3. Cell 171(5):1110–1124, 2017. DOI: 10.1016/j.cell.2017.09.039. https://doi.org/10.1016/j.cell.2017.09.039
  4. Lu A, Magupalli VG, Ruan J, Yin Q, Atianand MK, Vos MR, Schröder GF, Fitzgerald KA, Wu H, Egelman EH. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156(6):1193–1206, 2014. DOI: 10.1016/j.cell.2014.02.008. https://doi.org/10.1016/j.cell.2014.02.008
  5. Wang W, Hu D, Wu C, Feng Y, Li A, Liu W, Wang Y, Chen K, Tian M, Xiao F, Zhang Q, Shereen MA, Chen W, Pan P, Wan P, Wu K, Wu J. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathogens 16(3):e1008335, 2020. DOI: 10.1371/journal.ppat.1008335. https://doi.org/10.1371/journal.ppat.1008335
  6. Kabelitz D, Zarobkiewicz M, Heib M, Serrano R, Kunz M, Chitadze G, Adam D, Peters C. Signal strength of STING activation determines cytokine plasticity and cell death in human monocytes. Scientific Reports 12:17827, 2022. DOI: 10.1038/s41598-022-20519-7. https://doi.org/10.1038/s41598-022-20519-7
  7. Han C, Godfrey V, Liu Z, Han Y, Liu L, Peng H, Weichselbaum RR, Zaki H, Fu YX. The AIM2 and NLRP3 inflammasomes trigger IL-1–mediated antitumor effects during radiation. Science Immunology 6(59):eabc6998, 2021. DOI: 10.1126/sciimmunol.abc6998. https://doi.org/10.1126/sciimmunol.abc6998
  8. Guo X, Wang H, Li Y, Leng X, Huang W, Ma Y, Xu T, Qi X. Transfection reagent Lipofectamine triggers type I interferon signaling activation in macrophages. Immunology and Cell Biology 97(1):92–96, 2019. DOI: 10.1111/imcb.12194. https://doi.org/10.1111/imcb.12194
  9. Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nature Reviews Immunology 19:477–489, 2019. DOI: 10.1038/s41577-019-0165-0. https://doi.org/10.1038/s41577-019-0165-0
  10. Barnett KC, Li S, Liang K, Ting JPY. A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases. Cell 186(11):2288–2312, 2023. DOI: 10.1016/j.cell.2023.04.025. https://doi.org/10.1016/j.cell.2023.04.025
  11. Liu J, Zhou J, Luan Y, Li X, Meng X, Liao W, Tang J, Wang Z. cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation. Cell Communication and Signaling 22:22, 2024. DOI: 10.1186/s12964-023-01466-w. https://doi.org/10.1186/s12964-023-01466-w
  12. Hou Y, Lu H, Sun L, Zhang Y, Jiang H. Protocol for identification and validation of 2′3′-cGAMP-binding proteins by photoaffinity probes. STAR Protocols 3(1):101076, 2022. DOI: 10.1016/j.xpro.2021.101076. https://doi.org/10.1016/j.xpro.2021.101076
  13. Deng Y, Hahn Q, Yu L, Zhu Z, Boyer JA, Wang J, Kong D, Carey LM, Hepperla AJ, Simon JM, Temple B, Zhang Z, Zhang Y, Santos C, Frank JE, Herring LE, Wang X, Dokholyan NV, Campbell SL, Baldwin AS, Damania B, Zhang Q, Liu P. 2′3′-cGAMP interactome identifies 2′3′-cGAMP/Rab18/FosB signaling in cell migration control independent of innate immunity. Science Advances 10(42):eado7024, 2024. DOI: 10.1126/sciadv.ado7024. https://doi.org/10.1126/sciadv.ado7024
  14. Dai Z, Ma C, Ding H, Fu L, Jiang H, Tai S. Extracellular cGAMP in health and disease. Molecular Biomedicine 7:66, 2026. DOI: 10.1186/s43556-026-00464-x. https://doi.org/10.1186/s43556-026-00464-x
  15. Mertens RT, Misra A, Xiao P, Baek S, Rone JM, Mangani D, Sivanathan KN, Arojojoye AS, Awuah SG, Lee I, Shi GP, Petrova B, Brook JR, Anderson AC, Flavell RA, Kanarek N, Hemberg M, Nowarski R. A metabolic switch orchestrated by IL-18 and the cyclic dinucleotide cGAMP programs intestinal tolerance. Immunity 57(9):2077–2094.e12, 2024. DOI: 10.1016/j.immuni.2024.06.001. https://doi.org/10.1016/j.immuni.2024.06.001
  16. Kumar A, Stavrakis G, Karaba AH. Herpesviruses and inflammasomes: one sensor does not fit all. mBio 13(1):e01737-21, 2022. DOI: 10.1128/mbio.01737-21. https://doi.org/10.1128/mbio.01737-21